UL Solutions director awarded 19 deferred units

A UL Solutions director accrued 19 dividend-equivalent deferred restricted stock units linked to prior awards, vesting on 2025–2027 schedules and settling in Class A shares.

Rhea-AI Filing Summary

UL Solutions Inc. (symbol: ULS) is the issuer of record for a Form 4 filing submitted to the SEC. WILLIAMS GEORGE A reported acquisition or exercise transactions in this Form 4 filing.

UL Solutions Inc. (ULS) reported that director George A. Williams received three accruals of dividend-equivalent Deferred Restricted Stock Units (DRSUs) on September 10, 2026, covering an aggregate of 19 DRSUs, each representing one share of Class A Common Stock. These DRSUs relate to prior director awards and vest on the same schedules as the underlying DRSUs: one tranche tied to DRSUs that vested on May 1, 2025, one tied to DRSUs that vested on May 20, 2026, and one tied to DRSUs scheduled to vest on the earlier of May 20, 2027 or the annual meeting following the May 20, 2026 grant date, all to be settled in shares under the company’s Non-Employee Director Deferred Compensation Plan.

Insider Trade Summary

Grant/Award: 19 shares

Grant/Award 3 txns

Insider WILLIAMS GEORGE A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Restricted Stock Units F1, F2, F3, F4	10	$0.00	$0.00
Grant/Award	Deferred Restricted Stock Units F1, F2, F5, F4	5	$0.00	$0.00
Grant/Award	Deferred Restricted Stock Units F1, F2, F6, F4	4	$0.00	$0.00

Holdings After Transaction: Deferred Restricted Stock Units — 10,006 contracts (Direct)

Footnotes (6)

1. F1. Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. F2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
3. F3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
4. F4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.
5. F5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
6. F6. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

Key Figures

DRSUs acquired (tranche 1): 10 units DRSUs acquired (tranche 2): 5 units DRSUs acquired (tranche 3): 4 units +2 more

5 metrics

DRSUs acquired (tranche 1) 10 units Dividend-equivalent Deferred Restricted Stock Units acquired September 10, 2026; related DRSUs vested May 1, 2025

DRSUs acquired (tranche 2) 5 units Dividend-equivalent Deferred Restricted Stock Units acquired September 10, 2026; related DRSUs vested May 20, 2026

DRSUs acquired (tranche 3) 4 units Dividend-equivalent Deferred Restricted Stock Units acquired September 10, 2026; related DRSUs vest by May 20, 2027 or earlier annual meeting

Underlying Class A Common Stock per DRSU 1 share Each DRSU represents a contingent right to receive one share of Class A Common Stock

Transaction price per DRSU $0.00 Reported price per Deferred Restricted Stock Unit for all three September 10, 2026 accruals

Key Terms

Deferred Restricted Stock Units, dividend equivalent rights, Non-Employee Director Deferred Compensation Plan, contingent right

4 terms

Deferred Restricted Stock Units financial

"Each deferred restricted stock unit ("DRSU") represents a contingent right"

Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.

dividend equivalent rights financial

"Represents accrual of dividend equivalent rights on DRSUs held"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

Non-Employee Director Deferred Compensation Plan financial

"pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan"

contingent right financial

"represents a contingent right to receive one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UL Solutions Inc. (ULS) report for George A. Williams?

UL Solutions reported that director George A. Williams acquired 19 Deferred Restricted Stock Units on September 10, 2026 as dividend-equivalent accruals tied to previously granted DRSUs, with each unit representing one share of Class A Common Stock.

How many Deferred Restricted Stock Units did the ULS director receive on September 10, 2026?

On September 10, 2026, the director received 19 Deferred Restricted Stock Units in total, in three accruals of 10 DRSUs, 5 DRSUs, and 4 DRSUs, all at a reported price of $0.00 per unit as dividend-equivalent rights.

What does each Deferred Restricted Stock Unit represent for UL Solutions (ULS)?

Each Deferred Restricted Stock Unit (DRSU) represents a contingent right to receive one share of UL Solutions’ Class A Common Stock. The DRSUs reported here are dividend-equivalent rights that accrue on DRSUs already held by the director.

When do the reported ULS DRSU dividend-equivalent accruals vest and settle?

The 10-unit tranche relates to DRSUs that vested on May 1, 2025, the 5-unit tranche to DRSUs that vested on May 20, 2026, and the 4-unit tranche to DRSUs that vest on the earlier of May 20, 2027 or the next annual meeting, all settling in Class A shares under the director plan.

Were the UL Solutions (ULS) DRSU transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 plan for these transactions. The reported acquisitions are grant or award-type accruals of dividend-equivalent Deferred Restricted Stock Units rather than open-market trades.

Does the Form 4 show any sales of UL Solutions (ULS) stock by the director?

No. The Form 4 reports only acquisitions of derivative securities: three grant or award-type transactions of Deferred Restricted Stock Units totaling 19 units, with no sales or dispositions reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 05:46 PM Accepted by SEC EDGAR 09/14/2026 - 05:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILLIAMS GEORGE A

(Last) (First) (Middle)

C/O UL SOLUTIONS INC.

333 PFINGSTEN ROAD

(Street)

NORTHBROOK ILLINOIS 60062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UL Solutions Inc. [ ULS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units	(1)	09/10/2026		A		10(2)		(3)	(3)	Class A Common Stock	10	$0	4,979(4)	D
Deferred Restricted Stock Units	(1)	09/10/2026		A		5(2)		(5)	(5)	Class A Common Stock	5	$0	2,814(4)	D
Deferred Restricted Stock Units	(1)	09/10/2026		A		4(2)		(6)	(6)	Class A Common Stock	4	$0	2,213(4)	D

Explanation of Responses:

1. Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.

3. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.

4. Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.

5. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

6. The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

	/s/ Ryan Robinson, Attorney-in-Fact	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)